Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1,663
-
Total 13F shares, excl. options
-
1,009,356,244
-
Shares change
-
+2,414,676
-
Total reported value, excl. options
-
$73,295,492,986
-
Value change
-
+$193,423,902
-
Put/Call ratio
-
119%
-
Number of buys
-
747
-
Number of sells
-
-691
-
Price
-
$72.61
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q4 2021
1,853 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q4 2021.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,663 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,009,356,244 shares
of 1,240,722,841 outstanding shares and own 81.35% of the company stock.
Largest 10 shareholders include BlackRock Inc. (118,961,206 shares), Capital Research Global Investors (107,156,981 shares), VANGUARD GROUP INC (105,803,799 shares), STATE STREET CORP (57,369,269 shares), Capital World Investors (42,681,624 shares), Dodge & Cox (37,174,777 shares), Capital International Investors (36,272,461 shares), GEODE CAPITAL MANAGEMENT, LLC (22,739,179 shares), MORGAN STANLEY (15,629,396 shares), and NORTHERN TRUST CORP (14,538,441 shares).
This table shows the top 1663 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.